Skip to main content

Day: May 30, 2022

PRESS RELEASE: NACON: 2021-22 ANNUAL SALES IN LINE WITH EXPECTATIONS

Nacon                                                      Press release Lesquin, 30 May 2022, 18:00hrs 2021-22 ANNUAL SALES IN LINE WITH EXPECTATIONS155.9 M€ SALES 19.0 M€ CURRENT OPERATING INCOMESTRONG GROWTH MOMENTUM EXPECTED IN 2022-23:SALES OVER 250 M€ CURRENT OPERATING MARGIN EXCEEDING 50 M€  NACON (ISIN FR0013482791) today releases its audited consolidated results for FY 2021/22 (from April 1, 2021 to March 31, 2022) as approved by its Board of directors on 30 May 2022.Consolidated in M€ IFRS 2021–2022 2020–2021         ChangeSales 155.9 177.8 -12.3%Gross MarginIn % of sales EBITDAIn % of sales77.849.9% 44.628.6%93.552.6% 60.333.9% -16.7% -26.0%Current Operating IncomeIn % of sales Non recurrent items 19.012.2% (5.7) 32.518.3% (5.1)-41.6%Operating IncomeIn % of sales 13.38.6% 27.515.4% -51.4%Financial...

Continue reading

Offer Period for Intertrust Offer extended until 19 August 2022

JOINT PRESS RELEASE This is a joint press release by Intertrust N.V. (“Intertrust” or the “Company”) and CSC (Netherlands) Holdings B.V. (the “Offeror”), pursuant to the provisions of Section 15, paragraph 2 of the Netherlands Decree in Public Takeover Bids (Besluit openbare biedingen Wft, the “Decree”) in connection with the recommended public offer (the “Offer”) by the Offeror for all the issued and outstanding ordinary shares in the capital of Intertrust. This announcement does not constitute an offer, or any solicitation of any offer, to buy or subscribe for any securities in Intertrust. Any offer will be made only by means of an offer memorandum (the “Offer Memorandum”) approved by the Dutch Authority for Financial Markets (Stichting Autoriteit Financiële Markten, the “AFM”) which has been published on 31 March 2022, and subject to...

Continue reading

VELCAN HOLDINGS: CONVENING NOTICE OF THE ORDINARY ANNUAL GENERAL MEETING TO BE HELD ON 30th JUNE 2022

PRESS RELEASE Luxembourg, 30th May 2022 VELCAN HOLDINGS: CONVENING NOTICE OF THE ORDINARY ANNUAL GENERAL MEETING TO BE HELD ON 30thJUNE 2022 VELCAN HOLDINGS announces to the shareholders of the Company that the Ordinary Annual General Meeting will be held on Thursday the 30th of June 2022, at 3 p.m, in the offices of the law firm Tabery & Wauthier, 10 rue Pierre d’Aspelt, L‐1142 Luxembourg, in order to vote mainly on the approval of the 2021 condensed non-audited consolidated financial statements and of the 2021 audited statutory financial statements; All required information and related documents will be available for downloading on the Company’s website on 30th May 2022:Convening notice of the Ordinary Annual General Meeting; Board of Directors’ report on the resolutions proposed to the General Meeting; Text of the proposed resolutions; Single...

Continue reading

Kering: Press release – Disclosure of Transactions in Own Shares – May 23 to 27, 2022

  Paris, May 30, 2022,     Disclosure of Transactions in Own Shares   In accordance with the authorization given by the shareholders’ annual meeting on July 6, 2021 to trade on its own shares and pursuant to applicable law on share repurchase, Kering (LEI: 549300VGEJKB7SVUZR78) declares the following purchases of its own shares (FR0000121485) from May 23 to 27, 2022:  Issuer’s name Issuer’s identifying code Date of transaction Identifying code of financial instrument Aggregated daily volume (in number of shares) Daily weighted average price of the purchased shares Market (MIC code)KERING 549300VGEJKB7SVUZR78 23/05/2022 FR0000121485 21 350 450.6116 XPARKERING 549300VGEJKB7SVUZR78 23/05/2022 FR0000121485 2 650 450.9472 CEUXKERING 549300VGEJKB7SVUZR78 24/05/2022 FR0000121485...

Continue reading

Aspo’s subsidiary Leipurin acquires Kobia AB and strengthens its position in the Western market in accordance with Aspo’s strategy

Aspo PlcInside informationMay 30, 2022 at 17:35 p.m. Aspo’s subsidiary Leipurin acquires Kobia AB and strengthens its position in the Western market in accordance with Aspo’s strategy Aspo’s subsidiary Leipurin has agreed to purchase the entire share capital of the Swedish bakery industry distributor Kobia Ab from the Swedish Abdon Group. The acquisition will expand Leipurin’s geographical presence in the Northern European market. In 2021, Kobia’s net sales amounted to approximately EUR 50 million and its operating profit margin was approximately 3%. The transaction also includes the properties owned by Kobia, and the acquisition will not generate significant goodwill. The acquisition price is not disclosed. Through the acquisition, Leipurin further strengthens its position as a leading player in the Baltic Sea region, with increased...

Continue reading

Irwin Naturals Files Q1 2022 Financials

Cannabis Licensing and Ketamine ClinicRollup Strategy Accelerating Growth Company to host conference call Tuesday, May 31, 2022 at 2:00 pm EST LOS ANGELES, May 30, 2022 (GLOBE NEWSWIRE) — Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) announced the Company filed results for its first quarter of fiscal 2022, the period ended March 31, 2022 on www.sedar.com. Philippe Faraut, CFO, stated, “Revenues were slightly impacted by supply chain issues related to a fire at a key supplier producing our CBD product line. These issues were resolved and, subsequent to the quarter, CBD sales are trending back to normal. Further impacts came from product transitions and order timing. Profitability remained strong with an 11.2% operating margin  despite start-up expenses related to building our cannabis licensing...

Continue reading

The Harbourfront Group of Companies Reports First Quarter 2022 Financial Results

VANCOUVER, British Columbia, May 30, 2022 (GLOBE NEWSWIRE) — The Harbourfront Group of Companies (“The Harbourfront Group”), including Harbourfront Wealth Management Inc. (“Harbourfront” or “The Company”), today announced its results for the first quarter ended on March 31, 2022. For the quarter, The Harbourfront Group reported a revenue increase of 11% year over year (YOY) to its board of directors. Harbourfront continues to maintain a 100% advisor retention rate and onboarded new teams in the first quarter, resulting in a 40% YOY increase in assets under administration (AUA), bringing the company’s total AUA to over CAD $4 billion and assets under management (AUM) to over CAD $1.7 billion. “Harbourfront is continuing its growth trajectory by attracting astute advisors who recognize the value of the unique product offerings available...

Continue reading

Inflammatory Bowel Disease Treatment Market Size [2022-2029]: $37.00 Billion by 2029 at CAGR of 5.7%

According To Fortune Business Insights, The Global Inflammatory Bowel Disease Treatment Market Size Is Projected To Reach USD 37.00 Billion By 2028, Exhibiting A CAGR Of 5.5% During Forecast Period; Strong Focus on R&D for Treatment of Inflammatory Bowel Disease to Augment Market Growth Pune, India, May 30, 2022 (GLOBE NEWSWIRE) — The global inflammatory bowel disease treatment market size was valued at USD 23.90 billion in 2021. The market is projected to grow from USD 25.18 billion in 2022 to USD 37.00 billion by 2029, exhibiting a CAGR of 5.7% during the forecast period. This information is published by Fortune Business Insights, in its report titled, “Inflammatory Bowel Disease Treatment Market, 2022-2029.” The ulcerative colitis segment is anticipated to witness significant growth over the forecast period due to the high...

Continue reading

Form 8.3 – [Secure Income REIT plc – 27 05 2022] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree SECURE INCOME REIT PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position...

Continue reading

Form 8.3 – [LXi REIT plc – 27 05 2022] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree LXI REIT PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position held/dealing...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.